360
Views
3
CrossRef citations to date
0
Altmetric
Review Articles

Efficacy and safety of direct oral anticoagulants for treatment of left ventricular thrombus; a systematic review

ORCID Icon, , &
Pages 825-829 | Received 03 Feb 2021, Accepted 03 Mar 2021, Published online: 10 May 2021

References

  • Turgay Yildirim Ö, Akşit E, Aydin F, et al. Efficacy of direct oral anticoagulants on left ventricular thrombus. J Thromb Thrombolysis. 2019;44:1.
  • Fleddermann AM, Hayes CH, Magalski A, Main ML. Efficacy of direct acting oral anticoagulants in treatment of left ventricular thrombus. Am J Cardiol. 2019;124:367–372.
  • Tomasoni D, Sciatti E, Bonelli A, et al. Direct oral anticoagulants for the treatment of left ventricular thrombus – a new indication? A meta-summary of case reports. J Cardiovasc Pharmacol. 2020;75:530–534.
  • Sedhom R, Abdelmaseeh P, Megaly M, et al. Use of direct oral anticoagulants in the treatment of left ventricular thrombi: a systematic review. Am J Med. 2020;590:584–590.
  • Yassin AS, Abubakar H, Mishra T, et al. Rivaroxaban for left ventricular thrombus. Am J Ther. 2019;26:e511–e515.
  • Bagot CN, Arya R. Virchow and his triad: a question of attribution. Br J Haematol. 2008;143:180–190.
  • Brotman DJ, Deitcher SR, Lip GY, et al. Virchow's triad revisited. South Med J. 2004;97(2):213–214.
  • Y-Hassan S, Holmin S, Abdula G, et al. Thrombo-embolic complications in takotsubo syndrome: review and demonstration of an illustrative case. Clin Cardiol. 2019;42:312–319.
  • Habash F, Vallurupalli S. Challenges in management of left ventricular thrombus. Ther Adv Cardiovasc Dis. 2017;11:203–213.
  • Elikowski W, Małek-Elikowska M, Wróblewski D, et al. Apixaban in left ventricular thrombi treatment – a report of seven cases. Pol Merkur Lekarski. 2018;44:276–279.
  • Smetana KS, Dunne J, Parrott K, et al. Oral factor Xa inhibitors for the treatment of left ventricular thrombus: a case series. J Thromb Thrombolysis. 2017;44:519–524.
  • Jones DA, Wright P, Alizadeh MA, et al. The use of novel oral anti-coagulant’s (NOAC) compared to vitamin K antagonists (warfarin) in patients with left ventricular thrombus after acute myocardial infarction (AMI). Eur Hear J Cardiovasc Pharmacother. 2020.
  • Leow AST, Sia CH, Tan BYQ, et al. A meta-summary of case reports of non-vitamin K antagonist oral anticoagulant use in patients with left ventricular thrombus. J Thromb Thrombolysis. 2018;46:68–73.
  • Guyatt GH, Akl EA, Crowther M, et al., American College of Chest Physicians Antithrombotic Therapy and Prevention of Thrombosis Panel. Executive summary: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012;141:7S–47S.
  • Ruff CT, Giugliano RP, Braunwald E, et al. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. Lancet. 2014;383:955–962.
  • Manesh RP, Kenneth WM, Jyotsna G, et al., for the ROCKET AF Investigators*. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med. 2011;365:883–891.
  •  Christopher BG, John HA, John JVM, et al., for the ARISTOTLE Committees and Investigators*. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2011;365:981–992.
  • Keren A, Goldberg S, Gottlieb S, et al. Natural history of left ventricular thrombi: their appearance and resolution in the posthospitalization period of acute myocardial infarction. J Am Coll Cardiol. 1990;15:790–800.
  • Asinger RW, Mikell FL, Elsperger J, et al. Incidence of left-ventricular thrombosis after acute transmural myocardial infarction: serial evaluation by two-dimensional echocardiography. N Engl J Med. 1981;305:297–302.
  • Jugdutt BI, Sivaram CA, Wortman C, et al. Prospective two-dimensional echocardiographic evaluation of left ventricular thrombus and embolism after acute myocardial infarction. J Am Coll Cardiol. 1989;13:554–564.
  • Cochran JM, Jia X, Kaczmarek J, et al. Direct oral anticoagulants in the treatment of left ventricular thrombus: a retrospective, multicenter study and meta-analysis of existing data. J Cardiovasc Pharmacol Ther. 2021;26:173–178.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.